Axa’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Axa’s Portfolio NXGN Stock Details NXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-119,300	Closed	-$1.94M	–	1179
2023 Q2	$1.94M	Buy	+119,300	New	+$1.98M	0.01%	736
2023 Q1	–	Sell	-86,750	Closed	-$1.63M	–	1204
2022 Q4	$1.63M	Hold	86,750	–	–	0.01%	811
2022 Q3	$1.54M	Sell	86,750 -54,000	-38%	-$937K	0.01%	799
2022 Q2	$2.45M	Sell	140,750 -36,950	-21%	-$704K	0.01%	741
2022 Q1	$3.72M	Sell	177,700 -8,600	-5%	-$165K	0.01%	727
2021 Q4	$3.31M	Sell	186,300 -21,400	-10%	-$344K	0.01%	759
2021 Q3	$2.93M	Buy	207,700 +25,500	+14%	+$397K	0.01%	783
2021 Q2	$3.02M	Sell	182,200 -107,200	-37%	-$1.92M	0.01%	807
2021 Q1	$5.24M	Sell	289,400 -2,300	-0.8%	-$45.4K	0.02%	694
2020 Q4	$5.32M	Hold	291,700	–	–	0.02%	679
2020 Q3	$3.72M	Sell	291,700 -10,300	-3%	-$132K	0.01%	704
2020 Q2	$3.32M	Buy	302,000 +93,000	+44%	+$964K	0.01%	718
2020 Q1	$2.18M	Hold	209,000	–	–	0.01%	716
2019 Q4	$3.36M	Buy	209,000 +13,635	+7%	+$225K	0.01%	719
2019 Q3	$3.06M	Sell	195,365 -17,800	-8%	-$296K	0.01%	783
2019 Q2	$4.24M	Sell	213,165 -41,100	-16%	-$768K	0.02%	699
2019 Q1	$4.28M	Buy	254,265 +146,311	+136%	+$2.54M	0.02%	688
2018 Q4	$1.64M	Sell	107,954 -38,546	-26%	-$661K	0.01%	864
2018 Q3	$2.94M	Sell	146,500 -152,800	-51%	-$3.24M	0.01%	804
2018 Q2	$5.84M	Sell	299,300 -52,500	-15%	-$830K	0.02%	616
2018 Q1	$4.8M	Hold	351,800	–	–	0.02%	666
2017 Q4	$4.78M	Buy	351,800 +204,100	+138%	+$2.93M	0.02%	663
2017 Q3	$2.32M	Buy	147,700 +1,400	+1%	+$22.6K	0.01%	785
2017 Q2	$2.52M	Sell	146,300 -3,900	-3%	-$59.3K	0.01%	747
2017 Q1	$2.29M	Hold	150,200	–	–	0.01%	750
2016 Q4	$1.98M	Buy	150,200 +1,700	+1%	+$21.8K	0.01%	766
2016 Q3	$1.68M	Buy	148,500 +26,700	+22%	+$321K	0.01%	801
2016 Q2	$1.45M	Buy	+121,800	New	+$1.64M	0.01%	808

Other funds holding NXGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Axa's NXGN Position: Q3 2023 in Review

Axa sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q3 2023, closing a stake of 119,300 shares — an estimated $1.94M sold.

Axa first reported a position in NXGN in Q2 2016 and held it in 28 quarters. The position peaked at $5.84M in Q2 2018. 214 funds tracked by Wall St. Rank hold NXGN as of Q3 2023.

Axa reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Axa sold 119,300 NextGen Healthcare, Inc. Common Stock shares in Q3 2023, an estimated $1.94M.
Axa first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2016 and held it in 28 quarters.
Axa's NextGen Healthcare, Inc. Common Stock position peaked at $5.84M in Q2 2018.
214 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q3 2023.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.